193 related articles for article (PubMed ID: 18089341)
1. Reduction of proteinuria during intensified antihypertensive therapy in children after renal transplantation.
Seeman T; Simková E; Kreisinger J; Vondrák K; Dusek J; Dvorák P; Stuchlikova H; Janda J
Transplant Proc; 2007 Dec; 39(10):3150-2. PubMed ID: 18089341
[TBL] [Abstract][Full Text] [Related]
2. Improved control of hypertension in children after renal transplantation: results of a two-yr interventional trial.
Seeman T; Simková E; Kreisinger J; Vondrák K; Dusek J; Gilík J; Dvorák P; Janda J
Pediatr Transplant; 2007 Aug; 11(5):491-7. PubMed ID: 17631016
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
Ellis D; Moritz ML; Vats A; Janosky JE
Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
[TBL] [Abstract][Full Text] [Related]
4. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
[TBL] [Abstract][Full Text] [Related]
5. Proteinuria in children after renal transplantation.
Seeman T; Simková E; Kreisinger J; Vondrák K; Dusek J; Dvorák P; Janda J
Transplant Proc; 2005 Dec; 37(10):4282-3. PubMed ID: 16387097
[TBL] [Abstract][Full Text] [Related]
6. Control of hypertension in children after renal transplantation.
Seeman T; Simková E; Kreisinger J; Vondrák K; Dusek J; Gilík J; Feber J; Dvorák P; Janda J
Pediatr Transplant; 2006 May; 10(3):316-22. PubMed ID: 16677355
[TBL] [Abstract][Full Text] [Related]
7. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
8. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
[TBL] [Abstract][Full Text] [Related]
9. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
10. Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage.
Lufft V; Kliem V; Hamkens A; Bleck JS; Eisenberger U; Petersen R; Ehlerding G; Maschek H; Pichlmayr R; Brunkhorst R
Clin Transplant; 1998 Oct; 12(5):409-15. PubMed ID: 9787950
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure control in kidney transplantation: therapeutic implications.
Premasathian NC; Muehrer R; Brazy PC; Pirsch JD; Becker BN
J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
[TBL] [Abstract][Full Text] [Related]
12. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory blood pressure monitoring in renal transplant patients: modifiable parameters after active antihypertensive treatment.
Oliveras A; Vázquez S; Hurtado S; Vila J; Puig JM; Lloveras J
Transplant Proc; 2004 Jun; 36(5):1352-4. PubMed ID: 15251330
[TBL] [Abstract][Full Text] [Related]
14. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment.
Niiranen TJ; Kantola IM; Vesalainen R; Johansson J; Ruuska MJ
Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616
[TBL] [Abstract][Full Text] [Related]
15. [Improved control of hypertension and its effect on graft function in children after renal transplantation].
Seeman T; Simková E; Kreisinger J; Vondrák K; Dusek J; Dvorák P; Janda J
Cas Lek Cesk; 2006; 145(8):635-8. PubMed ID: 16995419
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial.
Conen D; Tschudi P; Martina B
J Hum Hypertens; 2009 Feb; 23(2):122-9. PubMed ID: 18754021
[TBL] [Abstract][Full Text] [Related]
17. Ramipril in the treatment of proteinuria in children after renal transplantation.
Seeman T; Dusek J; Vondrák K; Janda J
Pediatr Transplant; 2010 Mar; 14(2):283-7. PubMed ID: 19686445
[TBL] [Abstract][Full Text] [Related]
18. Predominance of nocturnal hypertension in pediatric renal allograft recipients.
McGlothan KR; Wyatt RJ; Ault BH; Hastings MC; Rogers T; DiSessa T; Jones DP
Pediatr Transplant; 2006 Aug; 10(5):558-64. PubMed ID: 16856991
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory blood pressure, proteinuria and uric acid in children with IgA nephropathy and their correlation with histopathological findings.
Seeman T; Pohl M; John U; Dusek J; Vondrák K; Janda J; Stejskal J; Groene HJ; Misselwitz J
Kidney Blood Press Res; 2008; 31(5):337-42. PubMed ID: 18946224
[TBL] [Abstract][Full Text] [Related]
20. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
Hermida RC; Ayala DE; Khder Y; Calvo C
Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
